Navigation Links
R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany
Date:11/3/2010

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany -- BERLIN, November 3, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Economic News, Trends, Analysis Click to view news release full screen  

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany

 

BERLIN, November 3, 2010 /PRNewswire/ -- Demand for medical biotechnology in Germany grew in 2009, further proving that the economic crisis has been well managed by Europe's largest economy. Revenue in medical biotechnology has increased for a fifth consecutive year, coming in at over EUR 5.7 billion in 2009. This coincides with strong innovation, as hundreds of projects have been realized thanks to cooperation with R&D institutes in Germany. Germany Trade & Invest will have representatives on hand at this year's Open Innovation - Global Strategies in R&D conference on November 4-5 in Boston to share opportunities for American companies in Germany's medical biotechnology and medical device industries.

The importance of R&D for the future of these industries is confirmed by generous funding. At almost EUR 1 billion in 2009, research funding for medical technology remained constant despite the economic downturn. Companies active in the so-called red biotechnology segment are already utilizing Germany's innovative R&D infrastructure, with over 800 cooperation projects with R&D institutes in Germany reported last year. This network of partners facilitates innovation across the entire value chain. Cooperation with other companies, research institutions, and organizations is common, especially for small companies.

Over three quarters of German biotech companies have less than 30 employees. This industry structure allows for international companies of all sizes to easily enter the largest and strongest market in Europe and serve growing demand. Germany's infrastructure, ranked first worldwide by a 2010 World Bank study, enables companies to effectively serve the single European market from Germany.

With over 11,000 companies and 170,000 employees in the medical device industry and several hundred companies working in medical biotechnology, these healthcare industry segments are essential innovation drivers for Germany. Germany is Europe's patent leader with twice the share of registered patents as France and the UK combined. In 2009 German companies were granted over 11,000 patents at the European patent office.

Germany Trade & Invest representatives will be at this year's Open Innovation - Global Strategies in R&D conference in Boston, Massachusetts on November 4-5, 2010. Matchmaking with medical biotechnology and medical device companies will take place with the support of local partners Massachusetts Biotechnology Council (MassBio), Massachusetts Medical Device Industry Council (MassMedic), Massachusetts Life Sciences Center, and the Massachusetts Office of International Trade & Investment (MOITI). Partners from the regional economic development agencies of the federal states of Berlin (Berlin Partner), Mecklenburg-Vorpommern (Invest in Mecklenburg-Vorpommern), and Saxony-Anhalt (IMG Sachsen-Anhalt) will also highlight opportunities in these innovative regions in Eastern Germany.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest Robert Scheid Email: robert.scheid@gtai.com T: +49(0)30-200099-170 F: +49(0)30-200099-111
'/>"/>

SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
2. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
3. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
4. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
5. US Nanotechnology Instrument Manufacturer Proves the Success of R&D Stimulus
6. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
7. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
8. Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
9. UMass Boston Opens Venture Development Center to Expand R&D Activity
10. Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
11. In-demand Contemporary Research Reports on Biotechnology Markets Available at MCGroup.co.uk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... ... March 20, 2017 , ... ... of endogenous hormones to regulate homeostasis via their cognate nuclear receptors. By ... adverse reproductive, neurological, proliferative, and immunological disorders. EDC exposure can occur directly, ...
(Date:3/20/2017)... ... March 20, 2017 , ... Avexegen Therapeutics Inc., an innovative ... has entered into an exclusive global license agreement with Children’s Hospital Los Angeles ... (rare orphan disease) as well as Crohn’s Disease and Ulcerative Colitis. ...
(Date:3/20/2017)... ... March 20, 2017 , ... Charm ... plug & play system that counts Peel Plate microbial test colonies, stores plate ... secure, stand-alone unit has an internal computer, and is accurate within 10% of ...
(Date:3/20/2017)... ... 2017 , ... Park Systems, a leader in Atomic Force Microscopy (AFM) since ... from 5-7pm at their Santa Clara facility that will include craft beer and refreshments, ... Tae-Gon Kim. , Dr. Tae-Gon Kim, Senior researcher at imec Belgium and adjunct professor ...
Breaking Biology Technology:
(Date:3/7/2017)... 7, 2017   HireVue , the leading provider ... identify the best talent, faster, today announced the additions ... (CSO) and Diana Kucer as Chief Marketing ... executive team poised to drive continued growth in the ... year of record bookings in 2017. "Companies ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... -- Who risk to be deprived of its imprint ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT ... sensors using capacitive technology represent a fast growing market, ... an increase of 360% of the number of fingerprint ... sensor market between 2014 and 2017 (source : N+1 ...
Breaking Biology News(10 mins):